UNDERWRITING AGREEMENT between Intensity Therapeutics, Inc. and Roth Capital Partners, LLC as Representative of the Several Underwriters Intensity Therapeutics, Inc.Underwriting Agreement • November 2nd, 2022 • Intensity Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
The undersigned, Intensity Therapeutics, Inc., a corporation formed under the laws of the State of Delaware (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement (as hereinafter defined) as being subsidiaries or affiliates of Intensity Therapeutics, Inc., the “Company”), hereby confirms its agreement (this “Agreement”) with Roth Capital Partners, LLC (hereinafter referred to as “you” (including its correlatives) or the “Representative”) and with the other underwriters named on Schedule 1 hereto for which the Representative is acting as representative (the Representative and such other underwriters being collectively called the “Underwriters” or, individually, an “Underwriter”) as follows:
